Morgan Stanley Boosts Envista (NYSE:NVST) Price Target to $21.00

Envista (NYSE:NVST) had its price objective upped by equities researchers at Morgan Stanley from $19.00 to $21.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s target price suggests a potential downside of 21.74% from the stock’s current price.

Other equities analysts have also recently issued reports about the company. Citigroup initiated coverage on Envista in a report on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 price objective for the company. William Blair upgraded Envista from a “hold” rating to an “outperform” rating in a report on Friday, February 6th. UBS Group upped their price objective on Envista from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday, February 3rd. Wells Fargo & Company upped their price objective on Envista from $21.00 to $26.00 and gave the stock an “equal weight” rating in a report on Friday, February 6th. Finally, Stifel Nicolaus set a $31.00 price objective on Envista in a report on Friday, February 6th. Seven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $27.85.

Envista Price Performance

NVST opened at $26.84 on Friday. The stock has a 50-day moving average price of $26.91 and a 200-day moving average price of $23.72. Envista has a 12-month low of $15.49 and a 12-month high of $30.42. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $4.37 billion, a P/E ratio of 95.84, a PEG ratio of 1.85 and a beta of 0.98.

Envista (NYSE:NVST) last posted its quarterly earnings data on Thursday, February 5th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.During the same period in the previous year, the company posted $0.24 earnings per share. Envista’s revenue for the quarter was up 15.0% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities analysts predict that Envista will post 1.4 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, SVP Mischa Reis sold 9,675 shares of the stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total transaction of $290,250.00. Following the completion of the sale, the senior vice president directly owned 32,382 shares in the company, valued at $971,460. This represents a 23.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.99% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Envista

Institutional investors have recently bought and sold shares of the stock. Farther Finance Advisors LLC boosted its holdings in Envista by 317.6% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after acquiring an additional 1,026 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after acquiring an additional 1,504 shares during the period. Allworth Financial LP boosted its holdings in Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after acquiring an additional 776 shares during the period. UMB Bank n.a. boosted its holdings in Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after acquiring an additional 636 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after acquiring an additional 949 shares during the period.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.